Which of the following problems is associated with intravenous augmentation of synthetic al-pha1-antitrypsin for the patient with genetic emphysema?
a. Bronchospasm
b. Expense
c. Headache
d. Nausea
ANS: B
Difficulties with intravenous augmentation therapy include the substantial expense (approxi-mately $100,000 per year), the inconvenience of frequent intravenous infusions for life, and the infusion itself, which confers a theoretical risk of transmitting a blood-borne infection.
Health Professions
You might also like to view...
In the normal heart, this is the only pathway for conduction of atrial electrical impulses to the ventricles
A) AV node B) left bundle branch C) right bundle branch D) SA node
Health Professions
What is the leading cause of injury and death among the elderly?
A. Cancer B. Suicide C. Trauma from falls D. Heart disease
Health Professions